Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats
Original source: https://www.investing.com/news/stock-market-news/obesity-drugmaker-novo-nordisk-cuts-2025-outlook-posts-q1-profit-above-forecast-4027000
Read More »Original source: https://www.investing.com/news/stock-market-news/obesity-drugmaker-novo-nordisk-cuts-2025-outlook-posts-q1-profit-above-forecast-4027000
Read More »